Companies / AmyriAD
AmyriAD
Company
AmyriAD is developing a novel therapy to improve cognition and independent global function in patients with Alzheimer’s disease
AmyriAD has 2 investors on file, among them Elevat3 Capital and What If Ventures. Its site was last checked 12 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Elevat3 Capital
6 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (50%), Real Estate & Construction (33%), Fintech (17%).
See Elevat3 Capital's full profile · Who invests alongside it
More from What If Ventures
16 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (48%), AI & Machine Learning (33%), Education (10%).
See What If Ventures' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get AmyriAD and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Elevat3 Capital adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/amyriadtherapeutics.com/investors
# also
GET /v1/companies/amyriadtherapeutics.com
GET /v1/companies/amyriadtherapeutics.com/news